143 related articles for article (PubMed ID: 27727297)
1. Evaluating Soluble EMMPRIN as a Marker of Disease Activity in Multiple Sclerosis: Studies of Serum and Cerebrospinal Fluid.
Kaushik DK; Yong HY; Hahn JN; Silva C; Casha S; Hurlbert RJ; Jacques FH; Lisak R; Khan O; Ionete C; Larochelle C; Prat A; Bar-Or A; Yong VW
PLoS One; 2016; 11(10):e0163802. PubMed ID: 27727297
[TBL] [Abstract][Full Text] [Related]
2. EMMPRIN levels in serum of patients with amyotrophic lateral sclerosis.
Iłżecka J
Acta Neurol Scand; 2011 Dec; 124(6):424-8. PubMed ID: 21554254
[TBL] [Abstract][Full Text] [Related]
3. Impact of Minocycline on Extracellular Matrix Metalloproteinase Inducer, a Factor Implicated in Multiple Sclerosis Immunopathogenesis.
Hahn JN; Kaushik DK; Mishra MK; Wang J; Silva C; Yong VW
J Immunol; 2016 Nov; 197(10):3850-3860. PubMed ID: 27733550
[TBL] [Abstract][Full Text] [Related]
4. Extracellular matrix metalloproteinase inducer shows active perivascular cuffs in multiple sclerosis.
Agrawal SM; Williamson J; Sharma R; Kebir H; Patel K; Prat A; Yong VW
Brain; 2013 Jun; 136(Pt 6):1760-77. PubMed ID: 23687119
[TBL] [Abstract][Full Text] [Related]
5. Soluble EMMPRIN levels discriminate aortic ectasia in Marfan syndrome patients.
Rurali E; Perrucci GL; Gaetano R; Pini A; Moschetta D; Gentilini D; Nigro P; Pompilio G
Theranostics; 2019; 9(8):2224-2234. PubMed ID: 31149040
[TBL] [Abstract][Full Text] [Related]
6. Gingival crevicular fluid matrix metalloproteinase (MMP)-7, extracellular MMP inducer, and tissue inhibitor of MMP-1 levels in periodontal disease.
Emingil G; Tervahartiala T; Mãntylã P; Määttä M; Sorsa T; Atilla G
J Periodontol; 2006 Dec; 77(12):2040-50. PubMed ID: 17209789
[TBL] [Abstract][Full Text] [Related]
7. A novel anti-EMMPRIN function-blocking antibody reduces T cell proliferation and neurotoxicity: relevance to multiple sclerosis.
Agrawal SM; Silva C; Wang J; Tong JP; Yong VW
J Neuroinflammation; 2012 Apr; 9():64. PubMed ID: 22480370
[TBL] [Abstract][Full Text] [Related]
8. EMMPRIN: a novel regulator of leukocyte transmigration into the CNS in multiple sclerosis and experimental autoimmune encephalomyelitis.
Agrawal SM; Silva C; Tourtellotte WW; Yong VW
J Neurosci; 2011 Jan; 31(2):669-77. PubMed ID: 21228176
[TBL] [Abstract][Full Text] [Related]
9. Immune Parameters That Distinguish Multiple Sclerosis Patients from Patients with Other Neurological Disorders at Presentation.
Mouzaki A; Rodi M; Dimisianos N; Emmanuil A; Kalavrizioti D; Lagoudaki R; Grigoriadis NC; Papathanasopoulos P
PLoS One; 2015; 10(8):e0135434. PubMed ID: 26317430
[TBL] [Abstract][Full Text] [Related]
10. A Competitive ELISA for quantifying serum CD147: reduction of soluble CD147 levels in cancer patient sera.
Moonsom S; Tayapiwatana C; Wongkham S; Kongtawelert P; Kasinrerk W
Hybridoma (Larchmt); 2010 Feb; 29(1):45-52. PubMed ID: 20199151
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of gingival crevicular fluid cyclophilin a and extracellular matrix metalloproteinase inducer levels in different periodontal diseases.
Eren G; Türkoğlu O; Atmaca H; Atilla G
Arch Oral Biol; 2016 Aug; 68():162-6. PubMed ID: 27176139
[TBL] [Abstract][Full Text] [Related]
12. EMMPRIN, an upstream regulator of MMPs, in CNS biology.
Kaushik DK; Hahn JN; Yong VW
Matrix Biol; 2015; 44-46():138-46. PubMed ID: 25644103
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of lactic acid isomers, extracellular matrix metalloproteinase inducer, and matrix metalloproteinase-8 in vaginal fluid from women with vaginal disorders.
Beghini J; Linhares IM; Giraldo PC; Ledger WJ; Witkin SS
BJOG; 2015 Nov; 122(12):1580-5. PubMed ID: 25196575
[TBL] [Abstract][Full Text] [Related]
14. Evaluating biomarkers of neuronal degeneration and neuroinflammation in CSF of patients with multiple sclerosis-osteopontin as a potential marker of clinical severity.
Szalardy L; Zadori D; Simu M; Bencsik K; Vecsei L; Klivenyi P
J Neurol Sci; 2013 Aug; 331(1-2):38-42. PubMed ID: 23706476
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of extracellular matrix metalloproteinase inducer is associated with matrix metalloproteinase-1 and -2 in gingival tissues from patients with periodontitis.
Dong W; Xiang J; Li C; Cao Z; Huang Z
J Periodontal Res; 2009 Feb; 44(1):125-32. PubMed ID: 19515022
[TBL] [Abstract][Full Text] [Related]
16. Interleukin 18 and extracellular matrix metalloproteinase inducer cross-regulation: implications in acute myocardial infarction.
Xie SL; Chen YY; Zhang HF; Deng BQ; Shu XR; Su ZZ; Lin YQ; Nie RQ; Wang JF
Transl Res; 2015 Mar; 165(3):387-95. PubMed ID: 25267095
[TBL] [Abstract][Full Text] [Related]
17. Elevated antibody reactivity to measles virus NCORE protein among patients with multiple sclerosis and their healthy siblings with intrathecal oligoclonal immunoglobulin G production.
Persson L; Longhi S; Enarsson J; Andersen O; Haghigi S; Nilsson S; Lagging M; Johansson M; Bergström T
J Clin Virol; 2014 Sep; 61(1):107-12. PubMed ID: 25022622
[TBL] [Abstract][Full Text] [Related]
18. Cerebrospinal fluid and serum antibodies against neurofilaments in patients with amyotrophic lateral sclerosis.
Fialová L; Svarcová J; Bartos A; Ridzon P; Malbohan I; Keller O; Rusina R
Eur J Neurol; 2010 Apr; 17(4):562-6. PubMed ID: 19968709
[TBL] [Abstract][Full Text] [Related]
19. Urine matrix metalloproteinases and their extracellular inducer EMMPRIN in children with chronic kidney disease.
Musiał K; Bargenda A; Zwolińska D
Ren Fail; 2015 Jul; 37(6):980-4. PubMed ID: 25945606
[TBL] [Abstract][Full Text] [Related]
20. The impact of differential expression of extracellular matrix metalloproteinase inducer, matrix metalloproteinase-2, tissue inhibitor of matrix metalloproteinase-2 and PDGF-AA on the chronicity of venous leg ulcers.
Mwaura B; Mahendran B; Hynes N; Defreitas D; Avalos G; Adegbola T; Adham M; Connolly CE; Sultan S
Eur J Vasc Endovasc Surg; 2006 Mar; 31(3):306-10. PubMed ID: 16169261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
